Investmentaktiengesellschaft Fuer Langfristige Investoren… Exits Position in Dolby Laboratories (DLB)

Dolby Laboratories (DLB) : Investmentaktiengesellschaft Fuer Langfristige Investoren… has sold out all of its stake in Dolby Laboratories during the most recent quarter, according to the disclosure filed by the company on Apr 25, 2016 with the SEC. The investment management company has sold out 133,871 shares of Dolby Laboratories which is valued at $6,373,598.

Dolby Laboratories closed down -0.63 points or -1.32% at $46.98 with 7,58,613 shares getting traded on Monday. Post opening the session at $46.45, the shares hit an intraday low of $45.16 and an intraday high of $47.18 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

Other Hedge Funds, Including , Washington Trust Bank added DLB to its portfolio by purchasing 42 company shares during the most recent quarter which is valued at $2,000.Centurylink Investment Management Co boosted its stake in DLB in the latest quarter, The investment management firm added 9,365 additional shares and now holds a total of 41,563 shares of Dolby Laboratories which is valued at $1,765,596. Dolby Laboratories makes up approx 0.63% of Centurylink Investment Management Co’s portfolio.Next Financial Group Inc boosted its stake in DLB in the latest quarter, The investment management firm added 53 additional shares and now holds a total of 159 shares of Dolby Laboratories which is valued at $6,754. Crestpoint Capital Management sold out all of its stake in DLB during the most recent quarter. The investment firm sold 26,300 shares of DLB which is valued $1,129,585.

On the company’s financial health, Dolby Laboratories reported $0.82 EPS for the quarter, beating the analyst consensus estimate by $ 0.21 according to the earnings call on Apr 27, 2016. Analyst had a consensus of $0.61. The company had revenue of $274.30 million for the quarter, compared to analysts expectations of $263.96 million. The company’s revenue was up .9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.72 EPS.

Many Wall Street Analysts have commented on Dolby Laboratories. Company shares were Reiterated by Dougherty & Company on Apr 28, 2016 to “Buy”, Firm has raised the Price Target to $ 54 from a previous price target of $46 .Company shares were Reiterated by Dougherty & Company on Apr 25, 2016 to “Buy”, Firm has raised the Price Target to $ 46 from a previous price target of $38 .Dolby Laboratories was Downgraded by JP Morgan to ” Neutral” on Apr 8, 2016.

Dolby Laboratories Inc. (Dolby Laboratories) creates audio imaging and communication technologies that transform entertainment and communications at the cinema at home at work and on mobile devices. The Company licenses its audio technologies and also develops technologies aimed at enhancing voice conferencing communications and imaging. Additionally the Company provides products and services that enable entertainment content creators and distributors to produce encode transmit and playback content for consumer experiences. The Company designs and manufactures audio and imaging products for the film production cinema and television broadcast industries. Distributed in approximately 80 countries these products are used in content creation distribution and playback to enhance image and sound quality and improve transmission and playback.

Leave a Reply

Dolby Laboratories - Is it time to Sell?

Top Brokerage Firms are advising their investors on Dolby Laboratories. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.